Search results
Mary-Claire King (born February 27, 1946) is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits.
By integrating genomic analyses with brain mapping strategies, we are able to define possible disease-related processes and to identify potential targets for treatment. Representative publications: McClellan JM, King M-C. A tipping point in neuropsychiatric genetics. [Commentary].
Mary-Claire King, Ph.D. Discovering the Hereditary Breast Cancer Gene. Research Area: Cancer Prevention. Long before scientists completed mapping the human genome in 2003, geneticist Mary-Claire King discovered BRCA1, the first gene for a hereditary form of breast cancer.
Feb 9, 2015 · Mary-Claire King discovered BRCA1, the so-called breast cancer gene, and now believes every woman should be tested.
This month I am covering the life and career of Dr. Mary-Claire King, a distinguished scientist who has applied her talents to the good of humanity, and provides a clear ideal of what it means to truly impact society through research.
- 4 min
Mary-Claire King, PhD. Department of Medicine, Genome Sciences. Dr. King’s discovery has transformed the diagnosis, drug development, and treatment of inherited breast and ovarian cancer.
Apr 9, 2014 · When Mary-Claire King, Ph.D., now an American Cancer Society Research Professor at the University of Washington, discovered the genetic mutation that’s responsible for 5–10% of all breast cancers, the world was changed.
